Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.33 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TLR2 | O60603 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14642721 | 0.91 | ALDH1A1 (0.48) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL1357542 | 0.89 | TSHR (0.47) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL23768408 | 0.88 | ALDH1A1 (0.56) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL19543564 | 0.88 | ALDH1A1 (0.56) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL13563001 | 0.87 | TSHR (0.48) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL8522872 | 0.87 | ALDH1A1 (0.48) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL12024300 | 0.87 | TSHR (0.48) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL18738907 | 0.87 | LPAR1 (0.55) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL5502602 | 0.86 | TSHR (0.45) | ALDH1A1TSHRMEN1KMT2ATHRB | |
| SCHEMBL19543524 | 0.86 | MEN1 (0.50) | ALDH1A1TSHRMEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12453785-B2 | Macrocyclic chelators and methods of use thereof | JANSSEN BIOTECH, INC. (US) | 2025-10-28 | — | — | US | disclosed |
| CN-114127059-B | Macrocyclic chelators and methods of use thereof | 詹森生物科技公司 | 2024-09-24 | — | — | CN | disclosed |
| US-20230110178-A1 | Macrocyclic Chelators and Methods of Use Thereof | JANSSEN BIOTECH, INC. | 2023-04-13 | — | — | US | disclosed |
| US-11576986-B2 | Macrocyclic chelators and methods of use thereof | JANSSEN BIOTECH, INC. (US) | 2023-02-14 | — | — | US | disclosed |
| CN-114127059-A | Macrocyclic chelants and methods of use thereof | 詹森生物科技公司 | 2022-03-01 | — | — | CN | disclosed |
| US-20200353105-A1 | Macrocyclic Chelators and Methods of Use Thereof | JANSSEN BIOTECH, INC. | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200353105-A1 | Macrocyclic Chelators and Methods of Use Thereof | CLASP1, CLTC, CD47 | ALDH1A1 2977/4885TSHR 225/4885MEN1 173/4885 |
| US-11576986-B2 | Macrocyclic chelators and methods of use thereof | CLASP1, CLTC, CD47 | ALDH1A1 2977/4885TSHR 225/4885MEN1 173/4885 |
| US-20230110178-A1 | Macrocyclic Chelators and Methods of Use Thereof | CLASP1, CLTC, CD47 | ALDH1A1 2977/4885TSHR 225/4885MEN1 173/4885 |
| US-12453785-B2 | Macrocyclic chelators and methods of use thereof | CLASP1, CLTC, CD47 | ALDH1A1 2977/4885TSHR 225/4885MEN1 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.